SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-24-000469
Filing Date
2024-05-13
Accepted
2024-05-13 19:09:49
Documents
1
Group Members
ALI BEHBAHANIANTHONY A. FLORENCE, JR.CARMEN CHANGFOREST BASKETTMOHAMAD H. MAKHZOUMINEA 16 GP, LLCNEA PARTNERS 16, L.P.PAUL WALKERSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 16, L.P. / BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL nea16-bldiamond_18839.htm SC 13D/A 408489
  Complete submission text file 0001072613-24-000469.txt   410504
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 16, L.P. (Filed by) CIK: 0001694560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Subject) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91312 | Film No.: 24940950
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)